Glystatins (CoCensys)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGlystatins (CoCensys)
Drug Alias NameGlystatin 3000 series (CoCensys)Glystatin 2000 series (CoCensys)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsPainEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue Pharma Inc
Active IndicationsN/A
Inactive IndicationsPainEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A